This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.
JAMA oncology, 9(2), 242-250
Citation
Cheung, Irene Y; Mauguen, Audrey; Modak, Shakeel; Ragupathi, Govind; Basu, Ellen M; Roberts, Stephen S; Kushner, Brian H; Cheung, Nai-Kong. (2023). Effect of Oral β-Glucan on Antibody Response to Ganglioside Vaccine in Patients With High-Risk Neuroblastoma: A Phase 2 Randomized Clinical Trial.. JAMA oncology, 9(2), 242-250. https://doi.org/10.1001/jamaoncol.2022.5999